ROSAI DORFMAN DISEASE
Clinical trials for ROSAI DORFMAN DISEASE explained in plain language.
Never miss a new study
Get alerted when new ROSAI DORFMAN DISEASE trials appear
Sign up with your email to follow new studies for ROSAI DORFMAN DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare immune disorders: targeted pill shows promise
Disease control Recruiting nowThis study tests a drug called cobimetinib in children and adults with Langerhans cell histiocytosis (LCH) and related disorders that have not responded to standard treatment. Cobimetinib blocks a faulty growth signal in the cells causing the disease. The goal is to shrink tumors…
Matched conditions: ROSAI DORFMAN DISEASE
Phase: PHASE2 • Sponsor: Carl Allen • Aim: Disease control
Last updated May 26, 2026 04:36 UTC
-
New drug cocktail aims to tame rare immune disease
Disease control Recruiting nowThis study tests whether a combination of lenalidomide and dexamethasone can control Rosai-Dorfman disease, a rare condition where immune cells build up and cause swelling. About 40 adults who are newly diagnosed or whose disease has returned will receive the treatment. The goal …
Matched conditions: ROSAI DORFMAN DISEASE
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 26, 2026 04:35 UTC
-
New PET scan tracer could spot hidden cancers
Knowledge-focused Recruiting nowThis early-phase study is testing a new imaging agent called [68Ga]-pentixafor to see how well it lights up certain blood cancers and related disorders on PET/CT scans. About 30 adults with non-Hodgkin lymphoma, multiple myeloma, or histiocytic neoplasms will receive the agent an…
Matched conditions: ROSAI DORFMAN DISEASE
Phase: EARLY_PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 04:49 UTC